HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ding-Shinn Chen Selected Research

RNA (Ribonucleic Acid)

1/2022Metastatic tumor antigen 1 contributes to hepatocarcinogenesis posttranscriptionally through RNA-binding function.
9/2017Impact of occult hepatitis B on the clinical outcomes of patients with chronic hepatitis C virus infection: A 10-year follow-up.
11/2016Prevalence and clinical implications of IL28B genotypes in Taiwanese patients with chronic hepatitis C.
11/2015Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naïve Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study.
5/2015Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy.
1/2015On-treatment low serum HBV RNA level predicts initial virological response in chronic hepatitis B patients receiving nucleoside analogue therapy.
1/2012Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin.
1/2010Differential effects of interferon and lamivudine on serum HBV RNA inhibition in patients with chronic hepatitis B.
2/2006Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma.
11/2005Natural course and treatment of dual hepatitis B virus and hepatitis C virus infections.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ding-Shinn Chen Research Topics

Disease

88Infections
01/2022 - 01/2002
55Chronic Hepatitis B
06/2021 - 01/2002
45Hepatitis B
01/2022 - 01/2002
42Chronic Hepatitis C
12/2020 - 10/2002
35Fibrosis (Cirrhosis)
07/2021 - 09/2002
34Hepatocellular Carcinoma (Hepatoma)
04/2020 - 07/2002
25Neoplasms (Cancer)
01/2022 - 04/2002
18Hepatitis
06/2021 - 01/2002
14Liver Diseases (Liver Disease)
01/2020 - 09/2002
14Hepatitis C
05/2016 - 03/2002
12Virus Diseases (Viral Diseases)
01/2020 - 09/2003
11Liver Cirrhosis (Hepatic Cirrhosis)
04/2020 - 07/2005
10Chronic Hepatitis (Chronic Active Hepatitis)
06/2012 - 09/2002
7Carcinogenesis
01/2022 - 08/2006
6Viremia
12/2020 - 12/2003
6Insulin Resistance
10/2014 - 08/2005
4Liver Neoplasms (Liver Cancer)
12/2020 - 04/2012
4Fatty Liver
08/2014 - 01/2005
3Persistent Infection
01/2019 - 02/2009
3Coinfection
03/2016 - 01/2002
3Disease Progression
06/2014 - 01/2013
3Neoplasm Metastasis (Metastasis)
05/2009 - 07/2005
2Hyperbilirubinemia
03/2018 - 08/2014
2Obesity
01/2016 - 05/2010
2Body Weight (Weight, Body)
10/2015 - 07/2015
2Inflammation (Inflammations)
05/2010 - 08/2006
2Genetic Predisposition to Disease (Genetic Predisposition)
07/2006 - 11/2002
2Hepatic Encephalopathy
04/2004 - 01/2002
1Reinfection
01/2022
1Residual Neoplasm
12/2020

Drug/Important Bio-Agent (IBA)

45Hepatitis B e AntigensIBA
06/2021 - 01/2002
44Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2020 - 06/2002
40InterferonsIBA
06/2021 - 11/2002
36DNA (Deoxyribonucleic Acid)IBA
12/2020 - 01/2002
33Antiviral Agents (Antivirals)IBA
07/2021 - 03/2004
32Ribavirin (Virazole)FDA LinkGeneric
12/2020 - 11/2002
18Alanine Transaminase (SGPT)IBA
05/2015 - 01/2003
12RNA (Ribonucleic Acid)IBA
01/2022 - 06/2003
10VaccinesIBA
05/2020 - 03/2004
10Proteins (Proteins, Gene)FDA Link
01/2019 - 03/2002
9Biomarkers (Surrogate Marker)IBA
12/2020 - 05/2006
8AntigensIBA
12/2019 - 01/2002
8peginterferon alfa-2a (Pegasys)FDA Link
10/2015 - 02/2009
8Lamivudine (Epivir)FDA Link
10/2013 - 02/2002
7alpha-Fetoproteins (alpha-Fetoprotein)IBA
12/2019 - 01/2002
6Immunoglobulins (Immunoglobulin)IBA
01/2022 - 01/2004
6AdiponectinIBA
04/2015 - 08/2005
5Codon (Codons)IBA
07/2014 - 01/2002
4NucleotidesIBA
06/2021 - 10/2002
4SofosbuvirIBA
09/2019 - 01/2018
4BilirubinIBA
03/2018 - 01/2002
4Surface Antigens (Surface Antigen)IBA
03/2018 - 08/2013
4Triglycerides (Triacylglycerol)IBA
01/2016 - 06/2008
4LipidsIBA
01/2016 - 06/2008
4Aspartate Aminotransferases (Aspartate Transaminase)IBA
05/2015 - 11/2006
4Interferon-alpha (Interferon Alfa)IBA
01/2007 - 12/2002
3Neoplasm Antigens (Tumor Antigens)IBA
01/2022 - 07/2016
3CholesterolIBA
09/2020 - 06/2008
3glecaprevir and pibrentasvirIBA
01/2020 - 08/2019
3Androgen Receptors (Androgen Receptor)IBA
10/2015 - 08/2002
3Estrogens (Estrogen)FDA Link
02/2015 - 02/2009
3CytokinesIBA
08/2014 - 03/2004
3MicroRNAs (MicroRNA)IBA
01/2013 - 02/2009
3AndrogensIBA
08/2012 - 04/2007
3Amino AcidsFDA Link
01/2011 - 09/2002
3Hepatitis B Core AntigensIBA
05/2010 - 05/2006
3Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
03/2004 - 03/2002
2hepatitis B hyperimmune globulinIBA
01/2022 - 03/2015
2Circular DNAIBA
06/2020 - 08/2014
2CateninsIBA
01/2020 - 11/2011
2daclatasvirIBA
02/2019 - 01/2018
2ledipasvirIBA
01/2018 - 01/2018
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2018 - 01/2016
2Sorafenib (BAY 43-9006)FDA Link
11/2017 - 06/2015
2Interleukin-6 (Interleukin 6)IBA
06/2015 - 06/2012
2AdipokinesIBA
04/2015 - 08/2014
2NucleosidesIBA
01/2015 - 01/2013
2peginterferon alfa-2b (Pegintron)FDA Link
10/2014 - 07/2014
2Pharmaceutical PreparationsIBA
01/2013 - 01/2008
2Transaminases (Aminotransferases)IBA
07/2010 - 11/2006
2Blood Glucose (Blood Sugar)IBA
05/2010 - 06/2008
2Biological ProductsIBA
01/2010 - 10/2005
2N-acetyltalosaminuronic acid (NAT)IBA
05/2006 - 12/2002
2Immunoglobulin M (IgM)IBA
05/2006 - 01/2004
2Therapeutic UsesIBA
03/2004 - 05/2003
1ChromatinIBA
01/2022
1T140 peptideIBA
01/2022
1sofosbuvir velpatasvir voxilaprevir drug combinationIBA
12/2020
1Lipoproteins (Lipoprotein)IBA
09/2020
1Carrier Proteins (Binding Protein)IBA
04/2020
1Rituximab (Mabthera)FDA Link
01/2020

Therapy/Procedure

77Therapeutics
07/2021 - 04/2002
4Aftercare (After-Treatment)
01/2018 - 07/2005
4Duration of Therapy
04/2013 - 05/2005
3Immunotherapy
01/2019 - 05/2003
3Ligation
11/2017 - 06/2015
3Renal Dialysis (Hemodialysis)
05/2011 - 07/2010
2Drug Therapy (Chemotherapy)
01/2020 - 06/2013
2Kidney Transplantation
05/2011 - 07/2010
1Liver Transplantation
01/2022